期刊文献+

高糖刺激肾小球系膜细胞葡萄糖转运蛋白4及p21的表达及其意义 被引量:2

Expression of glucose transporter 4 and cyclin kinase inhibitor p21 in cultured glomerular mesangial cells stimulated by high glucose
原文传递
导出
摘要 目的探讨早期糖尿病肾病(DN)肾小球系膜细胞(GMC)中葡萄糖转运蛋白(GLUT)4、p21mRNA表达变化及其与GMC肥大的关系。方法大鼠1097系膜细胞株分为高糖组、甘露醇组、不同浓度胰岛素组、高糖加不同浓度胰岛素组、正常对照组。用RT-PCR法检测各组GLUT4mRNA、p21mRNA的表达。流式细胞仪测各组GMC体积大小。结果正常对照组GMC有一定GLUT4mRNA、p21mRNA表达。高糖组GLUT4mRNA表达明显下降,p21mRNA表达明显增加。胰岛素刺激GMCGLUT4mRNA表达存在浓度依赖关系。p21mRNA表达越高,细胞前向角度散射光(FSC)越强,GMC体积越大。结论高糖刺激导致GMC肥大,GMC的p21mRNA表达上调和GLUT4mRNA表达下调与DN早期GMC肥大-肾小球肥大有关。 Objective To elucidate the relationship between expressive level alteration of glucose transporter 4(GLUT 4) mRNA,cyclin kinase inhibitor p21 mRNA and glomerular mesangial cell(GMC) hypertrophy in cultured rat GMC.Methods Cultured rat 1097 GMCs were divided into high glucose group, mannitol group, different insulin concentration groups, high glucose plus different insulin concentration groups and control group. Semi quantity RT PCR and flow cytometery were used to detect GLUT 4mRNA and p21mRNA levels and GMC volume. Results A certain expression of GLUT 4mRNA and p21mRNA from GMC was found in control group. High glucose decreased GLUT 4mRNA level and increased p21mRNA level. Insulin up regulated GLUT 4mRNA expression in a dose dependent manner.The more p21mRNA expressed, the stronger forward scatter (FSC) was and the bigger GMC became. Conclusions High glucose can cause GMC hypertrophy. Up regulation of p21mRNA and down regulation of GLUT 4mRNA may be involved in GMC hypertrophy and glomerular hypertrophy in early diabetic nephropathy.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2004年第3期166-168,共3页 Chinese Journal of Nephrology
关键词 高糖刺激 肾小球系膜细胞 葡萄糖转运蛋白4 P21表达 糖尿病肾病 Diabetic nephropathy Glucose transporter 4 Cyclin dependent kinase inhibitor p21 Cellular hypertrophy
  • 相关文献

参考文献10

  • 1Shepherd PR, Kahn BB. Glucose transporters and insulin action for insulin resistance and diabetes mellitus. New Engl J Med, 1999,341: 248-257.
  • 2Shankland SJ. Cell cycle control and renal disease. Kidney Int,1997, 52: 294-308.
  • 3Sugiyama A, Nagaki M, Moriwaki H, et al. Regulation of cell cycle-related genes in rat hepatocytes by transforming growth factor-β. Biochem Physiol, 1997, 238: 539-543.
  • 4Marcus RG, England R, Nguyen K, et al. Altered renal expression of the insulin-responsive glucose transporter GLUT 4 in experimental diabetes mellitus. AmJ Physiol, 1994,270: F816-F824.
  • 5UKPDS group study. Intensive blood-glucose control with sulphonylureas, or insulin compared with conventional treatment and risk or complication in patient with type 2 diabetes (UKPDS 33) .Lancet, 1998, 352: 837.
  • 6Cary W, Kitt FP. Impaired glucose transporter as a cause of decreased insulin stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med, 1999, 341: 240-246.
  • 7Bonadonua RC, Delprato S. Roles of glucose transporter and glucose phosphylation in muscle insulin resistance of NIDDM. Diabetes,1996,45: 915-925.
  • 8陈雄辉,余学清,姜宗培,许韩师,杨念生,周建忠,关伟明.细胞周期抑制蛋白p21^(cipl)在狼疮肾炎肾组织中的表达及其意义[J].中华肾脏病杂志,2002,18(1):17-20. 被引量:5
  • 9Al-Awqati Q, Preising PA. Size does matter: will knockout of P21WAF1/cipl save the kidney by limiting compensatory renal growth.Proc Natl Acad Sci USA, 1999,96: 10551.
  • 10Al-Douahji M, Brugarolas J, Brown PA, et al. The cyclin kinase inhibitot P21WAD1/cipl is required for glomerular hypertrophy in experimental diabetic nephropathy. Kidney Int, 1999, 56 Suppl: 1661-1699.

二级参考文献8

  • 1Stuart JS. Cell-cyclin control and renal disease. Kidney Int, 1997,52: 294-308.
  • 2Toyochima H, Hatter T. p27, a novel inhibition of G1 cyclin-CDK protein kinase activity , is related to p21. Cell, 1994, 78: 67-74.
  • 3Conraol LP. Evaluation of kidney biopsy specimens. In: Tisher CC, Brenner BM, eds. Renal pathology. Philadelphia: J B Lippincott Company, 1994. 85-115.
  • 4Luo Y, Hurwite J, Massague. Cell-cyclin inhibition by independent CDK and PCNA binding domains in p21cipl. Nature, 1995, 375:159-161.
  • 5Wag A S, Hannon GJ, Beach D, et al. The p21cipl inhibitor ofcyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature, 1994, 369: 574-578.
  • 6Takemara T, Okada M, Akano N, et al. Proto-oncogene expression in human glomerular disease. J Pathol, 1996, 178:343-351.
  • 7Yamamoto T, Noble NA, Cohen AH, et al. Expression of transforming growth factor-beta isoforms in human glomerular disease. Kidney Int 1996,49: 461-469.
  • 8Shankland SJ, Huso C, Coats SR, et al. Change in cell-cyclin protein expression during experimental mesangial proliferative glomerulonephritis. Kindey Int, 1996,50: 1230-1239.

共引文献4

同被引文献20

  • 1唐万欣,4黄颂敏,柳飞,沙朝晖.高糖和胰岛素对肾小球系膜细胞葡萄糖转运蛋白4mRNA表达及细胞骨架纤维状肌动蛋白的影响[J].中华肾脏病杂志,2004,20(5):351-354. 被引量:9
  • 2杜新,赖学莉,黄颂敏.脂筏蛋白与Cb1相关蛋白在葡萄糖转运中的信号转导机制[J].国际病理科学与临床杂志,2006,26(2):135-138. 被引量:3
  • 3James DE, Brown R, Navarro J, et al. Insulin-regulatable tissues express an unique insulin-sensitive glucose transporter protein. Nature, 1998, 333(6169): 183.
  • 4Marcus RG, England R, Nguyen K, et al. Altered renal expression of the insulin-responsive glucose transporter GLUT4 in experimental diabetes mellitus. Am J Physiol, 1994, 267: F816-F824.
  • 5Omata W, Shibata H, Li L, et al. Actin filaments play a critical role in insulin-induced exocytotic recruitment but not in endocytosis of GLUT4 in isolated rat adipocytes. Biochem J, 2000, 346: 321-328.
  • 6Cline GW, Petersen KF, Krssak M, et al. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med, 1999, 341 : 240-246.
  • 7Petersen KF, Shulman GI. Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus. Am J Cardiol, 2002, 90:11G- 17G.
  • 8Antonescu CN, Foti M, Sauvonnet N, et al. Ready, set, internalize: mechanisms and regulation of GLUT4 endocytosis. Biosci Rep, 2009, 29: 1-11.
  • 9Valensin S, Paccani SR, Ulivieri C, et al. F-actin dynamics control segregation of the TCR signaling cascade to clustered lipid rafts. Eur J Immunol, 2002, 32: 435-446.
  • 10Kanzaki M, Pessin JE. Insulin-stimulated GluT4 translocation in adipocytes is dependent upon cortical actin remodeling. J Biol Chem, 2001, 276: 42436-42444.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部